A call to action: Overcoming barriers to allow treatment in community pharmacies (July 2019)
July 25, 2019
Introducing a new paper from the London Joint Working Group.
Fully embracing the strategic priorities and ambitions to eliminate hepatitis C as a public health threat by 2025, the London Joint Working Group have been exploring the options around the introduction of a community pharmacy hepatitis C treatment service. Despite full local system support for the initiative and examples of similar services being introduced successfully in Scotland, the work has come to an impasse due to the legislation, bureaucracy and overly complex processes associated with the commissioning of High Cost Non-National Tariff drugs.
This paper outlines the barriers to the implementation of a truly integrated and patient centered service and is aimed at stimulating debate in-order to influence legislative and commissioning change and reform.